Eric Bernabei.
​
MENLO PARK, Calif.—Avellino Labs, a biotechnology and genetic science company, has named Eric Bernabei as chief sales and marketing officer. Bernabei, who brings more than 20 years of clinical and commercial ophthalmic experience to the role, will oversee the strategic expansion of Avellino Labs’ genetic diagnostic and therapeutic technologies, the company said. Bernabei joins Avellino Labs after his most recent roles as global product and strategic marketing director with Alcon. Throughout his career, Bernabei has focused on introducing new and advanced eyecare technologies in various global, regional and country level leadership roles.

With his global experience and relationships with ophthalmic thought leaders, Bernabei will help translate the value of Avellino’s genomic technology to clinicians and shape market adoption.

In his new role, Bernabei’s immediate focus will be the development of a strategic marketing program focused on the growth of Avellino Labs’ expanding genetic service offerings and tapping leading specialty marketing firm HCB Health to support the initiative.

Before joining Avellino Labs, Bernabei actively managed multinational marketing and sales initiatives for medical device and pharmaceutical organizations, including extended in-market assignments in Asia and Europe for Alcon following clinical support roles at Becton Dickinson and Summit Technology.